Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dienogest versus drospirenone for adenomyosis-associated pain
TCTR20260827003Phase 3Not yet recruiting
- Sponsor
- Nachcha Urasasilp
- Start
- Jun 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of dienogest, drospirenone in adenomyosis, sponsored by Nachcha Urasasilp. Planned start Jun 2026; status: not yet recruiting.
02
Drugs
dienogestdrospirenone
03
Conditions
adenomyosis
Beyond the preview
Go deeper on TCTR20260827003.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20260827003.